• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭的新出现的流行情况。

The emerging epidemic of heart failure with preserved ejection fraction.

作者信息

Oktay A Afşin, Rich Jonathan D, Shah Sanjiv J

出版信息

Curr Heart Fail Rep. 2013 Dec;10(4):401-10. doi: 10.1007/s11897-013-0155-7.

DOI:10.1007/s11897-013-0155-7
PMID:24078336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3870014/
Abstract

Heart failure with preserved ejection fraction (HFpEF), which currently represents approximately 50 % of heart failure (HF) cases, is common and associated with high morbidity and mortality. Understanding the epidemiology of HFpEF has been difficult due to the challenges in HFpEF diagnosis and the heterogeneous etiologies and pathophysiologies that underlie HFpEF. Nevertheless, several high-quality epidemiology and observational registry studies of HFpEF demonstrate that an increasing prevalence of HFpEF in both the outpatient and inpatient settings, coupled with a lack of evidence-based effective treatments for HFpEF, is resulting in an emerging epidemic of HFpEF. In this review, we discuss the emerging HFpEF epidemic, focusing on: (1) reasons for the rising prevalence of HFpEF; (2) the abnormalities in cardiac structure and function that dictate the transition from risk factors to HFpEF; (3) novel HFpEF mechanisms that may underlie the increase in HFpEF prevalence; (4) prognosis of HFpEF; and (5) risk prediction in HFpEF. We conclude with 10 unanswered questions onHFpEF epidemiology thatwill be important areas for future investigation.

摘要

射血分数保留的心力衰竭(HFpEF)目前约占心力衰竭(HF)病例的50%,较为常见,且与高发病率和高死亡率相关。由于HFpEF诊断存在挑战,以及构成HFpEF的病因和病理生理学具有异质性,了解HFpEF的流行病学一直很困难。尽管如此,几项关于HFpEF的高质量流行病学和观察性登记研究表明,门诊和住院患者中HFpEF的患病率不断上升,再加上缺乏针对HFpEF的循证有效治疗方法,正导致HFpEF成为一种新的流行病。在本综述中,我们讨论了新出现的HFpEF流行病,重点关注:(1)HFpEF患病率上升的原因;(2)决定从危险因素转变为HFpEF的心脏结构和功能异常;(3)可能是HFpEF患病率增加基础的新HFpEF机制;(4)HFpEF的预后;以及(5)HFpEF中的风险预测。我们最后提出了10个关于HFpEF流行病学的未解决问题,这些问题将是未来研究的重要领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd8/3870014/dbb804d6ef38/nihms528342f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd8/3870014/dbb804d6ef38/nihms528342f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd8/3870014/dbb804d6ef38/nihms528342f1.jpg

相似文献

1
The emerging epidemic of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的新出现的流行情况。
Curr Heart Fail Rep. 2013 Dec;10(4):401-10. doi: 10.1007/s11897-013-0155-7.
2
Epidemiology of heart failure with preserved ejection fraction.射血分数保留型心力衰竭的流行病学。
Nat Rev Cardiol. 2017 Oct;14(10):591-602. doi: 10.1038/nrcardio.2017.65. Epub 2017 May 11.
3
Epidemiology of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的流行病学
Curr Heart Fail Rep. 2014 Dec;11(4):354-65. doi: 10.1007/s11897-014-0223-7.
4
Epidemiology and pathogenesis of heart failure with preserved ejection fraction.射血分数保留型心力衰竭的流行病学和发病机制。
Rev Cardiovasc Med. 2020 Dec 30;21(4):531-540. doi: 10.31083/j.rcm.2020.04.154.
5
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.射血分数保留和降低的心衰门诊患者中非心脏合并症的患病率及其对预后的影响:一项社区研究。
Eur J Heart Fail. 2018 Sep;20(9):1257-1266. doi: 10.1002/ejhf.1202. Epub 2018 Jun 19.
6
Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭的流行病学、诊断、病理生理学及初始处理方法
Cardiol Clin. 2022 Nov;40(4):397-413. doi: 10.1016/j.ccl.2022.07.001.
7
Heart failure with preserved ejection fraction: A growing global epidemic.射血分数保留的心力衰竭:日益严重的全球性流行病。
Aust J Gen Pract. 2019 Jul;48(7):465-471. doi: 10.31128/AJGP-03-19-4873.
8
Epidemiology of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的流行病学
Heart Fail Clin. 2014 Jul;10(3):377-88. doi: 10.1016/j.hfc.2014.04.003.
9
Obesity and heart failure with preserved ejection fraction: A growing problem.肥胖与射血分数保留的心力衰竭:日益严重的问题。
Trends Cardiovasc Med. 2018 Jul;28(5):322-327. doi: 10.1016/j.tcm.2017.12.003. Epub 2017 Dec 14.
10
The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.高敏心肌肌钙蛋白检测对射血分数保留与降低的稳定心力衰竭患者不良事件的预后价值。
Eur J Heart Fail. 2017 Dec;19(12):1638-1647. doi: 10.1002/ejhf.911. Epub 2017 Aug 28.

引用本文的文献

1
Sex based cardiovascular differences in adult and middle-aged hypertensive schlager mice.成年和中年高血压施拉格小鼠基于性别的心血管差异。
Sci Rep. 2025 Aug 28;15(1):31679. doi: 10.1038/s41598-025-16459-7.
2
Evaluation of neutrophil gelatinase-associated lipocalin (NGAL) levels as a biomarker for the early diagnosis of heart failure patients without of kidney disease.评估中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平作为无肾脏疾病的心力衰竭患者早期诊断生物标志物的情况。
J Cardiovasc Thorac Res. 2025 Jun 28;17(2):91-96. doi: 10.34172/jcvtr.025.33007. eCollection 2025 Jun.
3
Time to Mortality and Predictive Factors Among Adult Heart Failure Patients: Lessons From a Resource-Limited Setting.

本文引用的文献

1
United States life tables, 2008.《2008年美国生命表》
Natl Vital Stat Rep. 2012 Sep 24;61(3):1-63.
2
Abdominal contributions to cardiorenal dysfunction in congestive heart failure.充血性心力衰竭中心肾功能障碍的腹部贡献。
J Am Coll Cardiol. 2013 Aug 6;62(6):485-95. doi: 10.1016/j.jacc.2013.04.070. Epub 2013 Jun 7.
3
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南:美国心脏病学会基金会/美国心脏协会报告
成年心力衰竭患者的死亡时间及预测因素:来自资源有限环境的经验教训。
Cardiol Res Pract. 2025 Aug 7;2025:3968055. doi: 10.1155/crp/3968055. eCollection 2025.
4
Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.心力衰竭与代谢功能障碍相关脂肪性肝病联合管理的指南导向性医学策略。
Commun Med (Lond). 2025 Jul 28;5(1):312. doi: 10.1038/s43856-025-00951-2.
5
Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis.静脉注射铁剂治疗射血分数保留的心力衰竭患者缺铁:一项多变量分析
Int J Cardiol Heart Vasc. 2025 Jun 19;59:101723. doi: 10.1016/j.ijcha.2025.101723. eCollection 2025 Aug.
6
The Role of Renal Denervation in HFpEF.肾去神经支配在射血分数保留的心力衰竭中的作用
J Clin Med. 2025 Jun 10;14(12):4115. doi: 10.3390/jcm14124115.
7
A two-phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree development.一种用于识别心力衰竭患者中射血分数保留的心力衰竭的两阶段方法:风险评分评估和决策树开发。
ESC Heart Fail. 2025 Aug;12(4):3079-3085. doi: 10.1002/ehf2.15333. Epub 2025 May 28.
8
Obesity and Comorbidities in HFpEF: A Retrospective Cohort Analysis in a University Hospital Setting.射血分数保留的心力衰竭中的肥胖与合并症:大学医院环境下的一项回顾性队列分析
J Clin Med. 2025 May 12;14(10):3348. doi: 10.3390/jcm14103348.
9
Mavacamten Cardiac Myosin Inhibitor: Clinical Applications and Future Perspectives.麦卡姆坦(Mavacamten):一种心肌肌球蛋白抑制剂的临床应用及未来展望
Cureus. 2025 Apr 21;17(4):e82722. doi: 10.7759/cureus.82722. eCollection 2025 Apr.
10
Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis.肝脏生物标志物作为射血分数保留的心力衰竭预后预测指标:一项系统评价和荟萃分析。
BMC Cardiovasc Disord. 2025 Apr 2;25(1):244. doi: 10.1186/s12872-025-04647-2.
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
4
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.一种新型射血分数保留心力衰竭模式:合并症通过冠状动脉微血管内皮炎症导致心肌功能障碍和重构。
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15.
5
How do patients with heart failure with preserved ejection fraction die?射血分数保留的心力衰竭患者是如何死亡的?
Eur J Heart Fail. 2013 Jun;15(6):604-13. doi: 10.1093/eurjhf/hft062. Epub 2013 Apr 21.
6
Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis).胰岛素抵抗、亚临床左心室重构和肥胖悖论:MESA(动脉粥样硬化的多民族研究)。
J Am Coll Cardiol. 2013 Apr 23;61(16):1698-706. doi: 10.1016/j.jacc.2013.01.053.
7
Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center.1993-2010 年射血分数降低的晚期心力衰竭治疗和结局的时间趋势:来自大学转诊中心的发现。
Circ Heart Fail. 2013 May;6(3):411-9. doi: 10.1161/CIRCHEARTFAILURE.112.000178. Epub 2013 Mar 11.
8
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.基于社区队列的射血分数保留与降低的心衰患者新发心衰的发病率和流行病学:PREVEND 的 11 年随访研究。
Eur Heart J. 2013 May;34(19):1424-31. doi: 10.1093/eurheartj/eht066. Epub 2013 Mar 6.
9
Left ventricular fibrosis in atrial fibrillation.心房颤动中的左心室纤维化。
Am J Cardiol. 2013 Apr 1;111(7):996-1001. doi: 10.1016/j.amjcard.2012.12.005. Epub 2013 Jan 17.
10
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.预测心力衰竭新发病例的因素:射血分数保留与降低心力衰竭的差异。
Circ Heart Fail. 2013 Mar;6(2):279-86. doi: 10.1161/CIRCHEARTFAILURE.112.972828. Epub 2012 Dec 27.